Signage is displayed outdoors a CVS Well being Corp. retailer in Rock Island, Illinois, U.S., Aug. 7, 2018. Photograph: Daniel Acker/Bloomberg© 2018 Bloomberg Finance LP

CVS Well being isn’t able to promote its Omnicare lengthy-time period care pharmacy enterprise as a result of executives see potential in an getting old U.S. inhabitants with complicated prescription wants.

Wall Road analysts are starting to query whether or not Omnicare continues to be “strategic to the corporate” following CVS’ disclosure Wednesday that the lengthy-time period care enterprise triggered a “$2.2 billion goodwill impairment cost.” That information was the newest in a collection of challenges for the lengthy-time period care pharmacy enterprise since CVS purchased Omnicare in 2015 in a deal valued at almost $thirteen billion.

CVS acknowledged the lengthy-time period care enterprise continues to grapple with “business large challenges” which have stored Omnicare from dwelling as much as a progress fee the corporate had hoped for. “These challenges embrace decrease occupancy charges in expert nursing amenities, vital deterioration within the monetary well being of quite a few expert nursing facility clients which resulted in quite a lot of buyer bankruptcies in 2018, and continued facility reimbursement pressures,” CVS stated in its fourth quarter 2018 earnings report.

However there stays a booming market of seniors shifting into assisted dwelling and unbiased dwelling amenities which might be additionally served by Omnicare and that is still a progress alternative and CVS executives are bullish.

“The growth opportunity with Omnicare was always focused on the independent and assisted living spaces,” CVS CEO Larry Merlo informed analysts. “And people alternatives nonetheless exist. They usually’re in step with our technique of placing the client on the new place of remodeling care.”

When CVS bought Omnicare, the pharmacy big needed to increase within the rising enterprise of dishing out and managing prescriptions for the booming variety of People taking specialised medicine. More and more, People are taking costlier biologics past drugs and capsules they usually require specialty pharmacies to dispense them, working with an array of suppliers, notably for an getting older inhabitants in assisted dwelling and lengthy-time period care amenities.

“As you take a look at the Omnicare enterprise, do not lose sight of there was a specialty element of that enterprise, which has been absolutely built-in and fairly profitable for the enterprise,” Merlo stated. “So, I do not need to lose that factor of the acquisition.”